The US Bankruptcy Court gave an order approving the sale of certain assets of Pear Therapeutics, Inc. on May 23, 2023. The debtor has been authorized to sell its certain assets to Nox Health Group, Inc. for a purchase price of $3.90 million in cash plus assumption of the assumed liabilities plus any cure costs. The debtorâs assets include assets related to Somryst.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
May. 23 | Pear Therapeutics, Inc. Went Out of Business | CI |
May. 08 | Combined Liquidation Plan and Disclosure Statement Approved for Pear Therapeutics, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 142 | |
+47.46% | 54.63B | |
-6.26% | 39.92B | |
+37.07% | 38.82B | |
+14.36% | 26.86B | |
-11.17% | 26.22B | |
-22.15% | 18.78B | |
+26.46% | 12.21B | |
+0.93% | 12.16B | |
+27.68% | 11.94B |
- Stock Market
- Equities
- PEAR Stock
- News Pear Therapeutics, Inc.
- Motion for Asset Sale Approved for Pear Therapeutics, Inc.